ABSTRACT Probiotics are live, nonpathogenic microorganisms known to have a positive effect on the host by improving the natural balance of gut microbiota. The objective of this study was to determine the effects of administering probiotics (Primalac W/S) in ovo on hatchability, early post-hatch performance, and intestinal immune-related gene expression of broiler chicks. At embryonic day eighteen, 360 Cobb 500 eggs were injected with sterile water (sham), 1 × 10 5 , 1 × 10 6 , or 1 × 10 7 (P1, P2, and P3 respectively) probiotic bacteria. Another 90 eggs remained non-injected to serve as a negative control. Measurements and tissue samples were taken on day of hatch (DOH) and days 4, 6, 8, 15, and 22. No significant differences were seen among groups for hatchability, feed intake, feed conversion ratios, or mortality. Body weight of P2 was significantly greater than that of the negative control, sham and P1 on d 4, and that of the negative control and P1 on d 6. A similar pattern was observed for BW gain (BWG) from DOH to d 4. Real-time PCR was used to investigate the expression of immune-related genes in the ileum and cecal tonsils. Other than an initial upregulation of inducible nitric oxide synthase on DOH, in ovo probiotic supplementation was associated with downregulated expression of Toll-like receptors-2 and -4, inducible nitric oxide synthase, trefoil factor-2, mucin-2, interferon-γ, and interleukins-4 and -13 in both the ileum and cecal tonsils, though expression patterns differed based on treatment, tissue, and time point evaluated. Taken together, these results indicate that in ovo supplementation of the probiotic product Primalac does not impact hatchability, can improve performance during the first week post-hatch, and is capable of modulating gene expression in the ileum and cecal tonsils.
INTRODUCTION
During the period immediately following hatch, the immune system of the chick is immature and inefficient, rendering birds vulnerable to environmental threats. Due to the inadequacies in the neonatal chick immune system, immunomodulators are being sought after and studied in order to protect these birds during this immunologically sensitive time. Furthermore, with increasing concerns about antibiotic resistance, the European Union has placed a ban on the sub-therapeutic use of antibiotics as feed additives. Unfortunately, this ban has resulted in a decline of animal health (Castanon, 2007) . The risk of a ban being enacted in the United States has created an impetus for finding alternatives capable of maintaining animal health without impeding performance. Probiotics are one of the options under evaluation as an alternative with their potential to C 2016 Poultry Science Association Inc. Received July 19, 2016 . Accepted September 22, 2016 Corresponding author: RDalloul@vt.edu modulate the immune system and reduce the rate and severity of enteric infections in poultry (Pan and Yu, 2014; Getachew, 2016) . A probiotic, meaning "for life" in Greek, has been defined as "a live microbial feed supplement which beneficially affects the host animal by improving intestinal balance" (Fuller, 1989) .
A well-balanced gut microbiota is essential for animal health and performance, and probiotics maintain this eubiotic environment through a number of mechanisms including competitive exclusion. For poultry, supplementation of probiotics enhances growth and improves feed conversion in chickens and turkeys (Kabir, 2009; Getachew, 2016) . Manipulation of intestinal microbiota through the use of probiotics may also influence the immune response. Dietary administration of probiotics may help maintain a healthy balance of gut microbiota and provide protection against several enteric pathogens through stimulation of the mucosal immune system (Nava et al., 2005) . In this respect, probiotics have been shown to enhance the innate immune system by increasing antimicrobial peptide production, heterophil oxidative burst and degranulation, as well as augmenting the phagocytic capacity of macrophages (Farnell et al., 2006; Higgins et al., 2007; Stringfellow et al., 2011; Pan and Yu, 2014) . Not only do probiotics strengthen innate immunity, they also improve the adaptive immune system. Probiotics increase antibody production against many economically important disease agents such as Eimeria, Newcastle disease virus, and infectious bursal disease virus (Khaksefidi and Ghoorchi, 2006; Lee et al., 2007; Nayebpor et al., 2007) . Furthermore, probiotics have demonstrated their ability to increase T lymphocyte numbers and modulate production of several pro-inflammatory, T helper Type-1 (Th1) and T helper Type-2 (Th2) cytokines when provided in the diet, though discrepancies in cytokine production have been noted due to differences in the probiotic strains used Brisbin et al., 2010; Lee et al., 2010) . The immune enhancing capabilities of probiotics have resulted in the clearance of several economically important pathogens such as Eimeria spp., Salmonella spp., Escherichia coli, and Clostridium perfringens, further asserting their potential use as antibiotic alternatives Knap et al., 2010; Pender at al., 2016) .
For a commercial broiler, the incubation and neonatal periods represent approximately 50% of the productive lifespan of the bird. The time from embryonic day 18 to 4 days post hatch is critical for the survival and development of the chick (Ferket, 2006) , and in ovo technology represents one means to administer probiotics and promote early colonization of beneficial bacteria in order to stimulate intestinal and immune system development (Cox and Dalloul, 2015) . The objective of the current study was to determine the effects of in ovo administration of a Lactobacillus-based probiotic on hatchability, early post-hatch performance, and intestinal immunerelated gene expression of broiler chicks.
MATERIALS AND METHODS

Birds and In ovo Treatments
This project was approved and conducted under the guidelines of the Virginia Tech Institutional Animal Care and Use Committee. At embryonic d 18, 450 fertile Cobb 500 eggs were obtained from a commercial hatchery (Pilgrim's Pride, Broadway, VA) and transported to the Virginia Tech Turkey Research Center. Prior to injection, all eggs were candled to determine position of the air cell. Eggs were sanitized by swabbing the large end (outside of the air cell) with 0.5% sodium hypochlorite and once dried, they were sprayed with 70% isopropyl alcohol. To create a guide and avoid cracking, a pilot hole was made in the center of the air cell of those eggs receiving injections using a 1.5-inch (3.8 cm) 18-gauge needle fitted with a rubber stopper to prevent the needle from piercing the air cell membrane. Needles were disinfected in between each injection by dipping in 0.5% sodium hypochlorite. Next, 360 eggs were injected in the amnion with 100 μL of either sterile water (sham), 1 × 10 5 , 1 × 10 6 , or 1 × 10 7 (P1, P2, and P3 respectively) of a commercially available probiotic product (Primalac W/S, Star-Labs Inc., Clarksdale, MO) containing Lactobacillus acidophilus, Lactobacillus casei, Enterococcus faecium, and Bifidobacterium bifidum dissolved in sterile water. Injections were performed using a 1 mL syringe equipped with a 22-gauge, 1-inch short bevel needle. A new syringe and needle were used for each injection. The remaining 90 eggs were not injected and served as a negative control. Eggs were placed into one of 3 replicate hatching trays (30 eggs/tray). On day of hatch (DOH), birds were individually tagged, placed into floor pens with clean shavings (3 replicate pens/treatment), and provided water and standard non-medicated starter feed in mash form ad libitum. The diet was formulated to meet or exceed the nutrient requirements for broilers as recommended by the NRC (1994).
Hatchability and Post-Hatch Performance Parameters
On DOH, percent hatchability was recorded, and birds were weighed prior to placement and on d 4, 6, 8, 15, and 22. Mean BW for each treatment group was calculated from the individual bird replicates for each weigh day. Average BW gains (BWG) were calculated for each period and cumulatively based on individual bird weights. Feed intake (FI) of each group was measured at the same time periods as body weights (d 4, 6, 8, 15, 22) with cumulative averages calculated. Feed conversion ratio (FCR) was calculated using BWG and FI and adjusted for mortality. Mortality was recorded on a daily basis throughout the trial. On DOH, d 4, 6, 8, 15, and 22, 6 birds per treatment (2 birds/replicate) were randomly selected and euthanized by cervical dislocation. A section of the mid-ileum (approximately 3.5 cm) and cecal tonsils were sampled, rinsed in cold PBS, and placed in RNAlater (Qiagen, Germantown, MD) for subsequent gene expression analysis. The samples were stored at −80
Tissue Sampling for Gene Expression Analysis
• C until analysis.
Intestinal Gene Expression
Intestinal samples were removed from −80 • C and a 20 to 30 mg aliquot of each sample was weighed, placed into a 2 mL microcentrifuge tube along with a 5 mm stainless steel bead and 600 μL RLT lysis buffer, and homogenized using the TissueLyser II system (Qiagen) according to manufacturer's recommendation. Total RNA was extracted from individual intestinal tissues using the RNeasy mini kit following the animal tissue protocol (Qiagen). Following extraction, RNA was eluted by rinsing the column membrane twice with 25 μL RNase-free water. Total RNA concentration was determined at optical density (OD) 260 nm (NanoDrop-1000, Thermo Fisher Scientific, Waltham, MA) and RNA purity was verified by evaluating the ratio of OD 260 nm to OD 280 nm. Total RNA was diluted to 0.2 μg/μL in nuclease-free water. Reverse transcription was accomplished using the high capacity cDNA Reverse Transcription kit (Applied Biosystems, Carlsbad, CA) following the manufacturer's protocol, and the cDNA was stored at −20 • C. Quantitative real-time PCR (qRT-PCR) was performed using an ABI 7500 FAST Real-Time PCR System (Applied Biosystems). The cDNA was diluted 1:30 in nuclease-free water then 1 μL of the diluted cDNA was added to each well of a 96-well plate. Next, 9 μL of real-time PCR master mix containing 5 μL FAST SYBR Green Master Mix (Applied Biosystems), 0.5 μL each of 2 μM forward and reverse primers and 3 μL of sterile nuclease-free water per reaction were added to each well for a final volume of 10 μL. During the PCR reaction, samples were subjected to an initial denaturation phase at 95
• C for 20 sec followed by 40 cycles of denaturation at 95
• C for 3 sec and annealing and extension at 60
• C for 30 sec. Gene expressions for interleukin (IL)-4, IL-13, interferon (IFN)-γ, inducible nitric oxide synthase (iNOS), lipopolysaccharide-induced TNFalpha factor (LITAF), mucin (Muc)-2, trefoil factor (TFF)-2, Toll-like receptor (TLR)-2 and TLR-4 were analyzed using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous control. Each reaction was run in duplicate. Primers were designed (Table 1 ) using the Primer Express 3.0 software (Applied Biosystems) and synthesized by MWG Operon (Huntsville, AL). Results from qRT-PCR were analyzed using the 7500 Real-Time PCR software (Applied Biosystems). Average gene expression relative to the GAPDH endogenous control for each sample was calculated using the 2 −ΔΔCt method (Livak and Schmittgen, 2001 ). The calibrator for each gene was the average ΔCt value from the negative control group for each sampling day for each respective tissue.
Statistical Analysis
Results were analyzed using the Fit Model platform in JMP 9.0 (SAS Institute Inc., Cary, NC). For BW and BWG data, the model included in ovo treatment as a fixed effect and pen as a random effect. For hatchability, mortality, FI, and FCR, the model included in ovo treatment with pen representing the experimental unit. Percent hatchability and mortality data were arc sine transformed prior to analysis. Gene expression analysis was performed with in ovo treatment in the model with bird serving as the experimental unit.
Differences among experimental treatments were tested using Tukey-HSD following ANOVA. Values were considered statistically different at P ≤ 0.05. Results are reported as least squares means with pooled standard errors.
RESULTS
Hatchability and Post-Hatch Performance
In ovo treatment had no significant effect on hatchability during this study (hatchability ranged from 95.6% to 98.9%). Body weight on DOH was not affected by in ovo treatment, but on d 4 the P2 group had heavier BW when compared to the negative control, sham and P1 groups (P = 0.01) ( Table 2) . A similar pattern was observed on d 6 where the P2 birds had higher BW than negative control and P1 birds, but not the sham group. The P3 group also had a greater BW than the P1 group on d 6 (P = 0.03). Body weight gain of P2 was higher than that of the negative control and P1 from DOH to d 4 (P = 0.03) ( Table 3) . Differences were not noted at any other time point for BW or BWG. In ovo supplementation of Primalac did not significantly alter FI, FCR (Table 3) , or mortality (ranging from 1.5 to 5%).
Intestinal Gene Expression
Ileal TLR-2 expression was downregulated on d 4 in the P2 and P3 groups (P = 0.045) and on d 6 in the sham, P1 and P3 groups when compared to the negative control (P = 0.02) (Figure 1a ). There was a significant effect of in ovo treatment in the cecal tonsils on DOH where the sham injected birds had decreased levels of TLR-2 expression (P = 0.001) (Figure 1b) . On d 4, all injected groups had lower TLR-2 expression than the negative control (P = 0.02). Levels of TLR-2 were decreased in P2 chicks on d 6 (P = 0.001) as well as in P3 chicks on d 8 (P = 0.01).
On DOH, TLR-4 expression was lower in the ileum of sham injected and P2 birds when compared to the negative controls (P = 0.01) (Figure 2a) . Expression of TLR-4 was also downregulated on d 6 in the ileum of P3 birds when compared to the negative control and sham birds (P = 0.03). In the cecal tonsil, TLR-4 expression on DOH was upregulated in P3 chicks when compared to sham, P1 and P2, but not the negative control (P = 0.02) (Figure 2b ). Expression of TLR-4 was decreased in P3 on d 4 (P = 0.02) and on d 6 in P1 and P2 when compared to the controls (P = 0.002). Levels of TLR-4 mRNA were also decreased in P3 birds on d 6, but only in comparison to the negative control. On d 22, TLR-4 expression was downregulated in P3 when compared to the negative control, sham, and P1groups (P = 0.03).
Expression of iNOS was augmented in the ileum of P3 birds on DOH when compared to the negative control and sham groups, and in P1 and P2 when compared to the negative control only (P = 0.01) (Figure 3a) . On d 6, expression levels of iNOS were decreased in P1 when compared to the negative control, sham, and P2 groups, and in P2 and P3 when compared to the negative control only (P = 0.0004). Expression of iNOS was also reduced on d 8 in P3 birds when compared to the negative control and sham injected groups, while all probiotic supplemented groups had lower expression than the sham inoculated group (P = 0.01). When looking at iNOS expression in the cecal tonsils, levels were decreased in all injected groups on d 8 (P = 0.006) and in P3 on d 22 (P = 0.0001) (Figure 3b) .
Relative to the negative control, TFF-2 expression in the ileum was decreased on d 6 in all injected groups (P = 0.004) (Figure 4a ). Expression of TFF-2 in the cecal tonsils was downregulated in P2 and P3 birds on d 6 (P = 0.001) (Figure 4b ). Additionally, TFF-2 was downregulated on d 22 in P2 and P3 when compared to the negative control with P3 also exhibiting lower expression than P1 (P = 0.01).
Expression of Muc-2 in the ileum was not affected by in ovo treatment at any time point during this study. On DOH, there was a significant effect of in ovo Figure 3a . Effect of in ovo probiotic supplementation on relative iNOS expression in the ileum of Cobb 500 chicks. Relative gene expression (2 −ΔΔCt ) was calculated using the ΔΔCt method with GAPDH as the endogenous control and the average ΔCt value for the negative control birds on each day as the calibrator. Data are represented as least squares means. NEG = negative control, Sham = sham water injection, P1 = 1 × 10 5 probiotic bacteria, P2 = 1 × 10 6 probiotic bacteria, P3 = 1 × 10 7 probiotic bacteria. Bars lacking a common letter within each day differ significantly.
Figure 3b. Effect of in ovo probiotic supplementation on relative iNOS expression in the cecal tonsils of Cobb 500 chicks. Relative gene expression (2 −ΔΔCt ) was calculated using the ΔΔCt method with GAPDH as the endogenous control and the average ΔCt value for the negative control birds on each day as the calibrator. Data are represented as least squares means. NEG = negative control, Sham = sham water injection, P1 = 1 × 10 5 probiotic bacteria, P2 = 1 × 10 6 probiotic bacteria, P3 = 1 × 10 7 probiotic bacteria. Bars lacking a common letter within each day differ significantly. treatment in the cecal tonsils where Muc-2 expression was decreased in P2 and P3 chicks when compared to both control groups (P = 0.001) ( Figure 5 ). Expression of Muc-2 on d 6 was downregulated in the sham, P1, and P2 groups when compared to the negative controls, but upregulated in P3 when compared to the sham and P1 birds (P = 0.01). Birds in P2 had increased expression of Muc-2 on d 22 in relation to the negative controls, while P3 birds had decreased expression in comparison to the sham, P1 and P2 groups (P = 0.02).
On d 6, IFN-γ expression in the ileum was lower in P3 birds than both the negative control and sham injected groups (Figure 6a ). All injected groups displayed reduced IFN-γ levels when compared to the negative controls (P < 0.0001). Expression of IFN-γ was decreased on d 8 in the cecal tonsils of P3 birds when compared to the negative control and sham birds (P = 0.03) (Figure 6b ).
Ileal expression of LITAF on d 6 was downregulated in P1 and P2 birds when compared to the sham injected birds, but not the negative control birds (P = 0.04) (Figure 7 ). Significant differences were not observed for LITAF expression in the cecal tonsils.
Interleukin-4 expression in the ileum was decreased on d 4 in all groups when compared to the negative control (P = 0.002) (Figure 8a ). On d 6, the P1 group had lower IL-4 expression than both the negative control and sham groups, while expression in P2 and P3 were only found to be less than the negative control (P = 0.0003). Furthermore, expression of IL-4 on d 15 was lower in P3 than in the negative control, sham, and P1 groups. Expression of IL-4 was also reduced in P2 birds on d 15, but only when compared to the sham and P1 groups (P = 0.01). In the cecal tonsils, IL-4 expression was decreased on d 22 in P2 and P3 chicks when compared to both control groups and in P1 chicks when compared to the sham group only (P = 0.002) (Figure 8b ).
On d 6, IL-13 expression was downregulated in the ileum of P1 and P3 birds when compared to the negative control and sham injected birds (P = 0.04) (Figure 9a ). Expression levels of IL-13 were decreased in the cecal tonsils on DOH in P3 chicks relative to the negative control, sham, and P1 groups and in P2 chicks relative to the negative controls and P1 (P = 0.0002) (Figure 9b) . Following a similar pattern, IL-13 levels on d 4 were lower in P3 birds than either of the control groups while P2 was lower than the negative controls only (P = 0.001). All probiotic supplemented groups showed downregulation of IL-13 on d 8 in comparison to the sham group, but only P2 and P3 were found to be different from the negative controls (P = 0.003).
DISCUSSION
The aim of this study was to explore the effects of in ovo administration of the probiotic product Primalac W/S in broiler chicks. In this experiment, in ovo supplementation of probiotics had no effect on hatchability. Corroborating our findings, Edens et al. (1997) compared the hatchability of broiler embryos injected with Lactobacillus reuteri either in the air cell or the amniotic fluid to non-inoculated controls and found no differences among the treatment groups. Similar results were also seen in turkey embryos (Edens et al., 1997) . Alternatively, other researchers have found that in ovo injection of some probiotic bacteria can lead to significantly reduced hatchability (Cox et al., 1992; Meijerhof and Hulet, 1997). These findings suggest that the probiotic bacteria in Primalac can be safely administered in ovo without negatively impacting hatchability.
Probiotics may be utilized to alter the gut microbial profile in order to create conditions favorable to enhancing performance. During this study, augmented BW and BWG were noted in P2 birds on d 4 and d 6. Similarly, Edens et al. (1997) found that broiler chicks inoculated with L. reuteri and subsequently challenged with Salmonella Typhimurium or E. coli displayed increased BW when compared to the challenge only birds. Dietary supplementation of probiotics has also resulted in improved BWG and FCR in chickens (Khaksefidi and Ghoorchi, 2006; Nayebpor et al., 2007; Talebi et al., 2008; Ignatova et al., 2009; Kabir, 2009; Sen et al., 2012; Getachew, 2016) and turkeys (Torres-Rodriguez et al., 2007) . Despite the plethora of data demonstrating the positive effects of probiotics on performance, several researchers reported no significant enhancements due to probiotic supplementation (Rahimi et al., 2011; Seifert et al., 2011; Wolfenden et al., 2011; Getachew, 2016) . These discrepancies could be due to a variety of factors including, but not limited to, strain(s) of bacteria utilized, composition and viability of the probiotic, preparation method, dosage, application method, frequency of application, overall diet, drug interactions, and condition of the animal (Huang et al., 2004; Mountzouris et al., 2007) .
Modulation of the immune system by in ovo supplementation of probiotics in poultry and early establishment of beneficial microbiota may lead to increased overall health and well-being while decreasing the need for prophylactic drug use due to reduced infection rates. In spite of considerable amount of published data regarding the efficacy of probiotics in poultry, the exact mechanism of how probiotics modulate the immune system is still not fully understood. Additional research is required to further define the dynamic function of probiotics in terms of their immunomodulating capabilities against pathogens.
One of our goals was to identify patterns of gene expression underlying the effects of in ovo probiotic supplementation on the immune system. We assayed both ileum and cecal tonsil tissues for differences in gene expression using real-time PCR. To observe the effects of probiotics on innate immunity, we evaluated the expression of TLR-2, iNOS, . The TLR family is a highly conserved group of proteins that act as pathogen recognition receptors recognizing microbe-associated molecular patterns that are expressed on infectious agents. They play a fundamental role in pathogen detection and are responsible for the initiation and regulation of the innate response. When exposed to antigens or chemotactic agents, macrophages will begin to produce iNOS. This enzyme leads to the production of nitric oxide, which will subsequently react with superoxide anions to generate toxic derivatives, allowing macrophages to proficiently kill numerous types of pathogens (Tizard, 2009 ). The Muc-2 gene, which is mediated by T lymphocytes and Th2 cytokines, is responsible for encoding mucin production (Beum et al., 2005) . Mucin is made up of glycoproteins and serves a protective function by binding to pathogens, thus preventing their adhesion to the intestinal surface. Trefoil factor-2 is a stable secretory protein expressed in gastrointestinal mucosa responsible for protecting the epithelial layer from insults, stabilizing the mucus layer and promoting healing of the epithelium (Jiang et al., 2011) .
To evaluate effects on the adaptive immune response, we analyzed gene expression of LITAF, . Interferon-γ is a vital cytokine that plays a central role in regulating the innate and adaptive immune responses, and is responsible for promoting Th1 cell differentiation, suppressing Th2 cell activity, and enhancing innate immune cell activation and function (Kaiser and Staheli, 2008) . Expression of LITAF is principally in the spleen of chickens as well as in intestinal intraepithelial lymphocytes. The LITAF protein is a transcription factor that mediates the expression of members of the tumor necrosis factor ligand superfamily (Hong et al., 2006) . Interleukin-4, a representative of Th2 cytokines, plays a fundamental role in the stimulation of B lymphocytes, T lymphocyte proliferation and the differentiation of CD4+ T cells into Th2 cells (Fietta and Delsante, 2009 ). The functions of IL-13, also characterized as a Th2 cytokine, overlap considerably with those of IL-4. Both IL-4 and IL-13 function by inhibiting the production of pro-inflammatory modulators.
On DOH, all probiotic treatment levels resulted in increased expression of iNOS in the ileum when compared to the negative control, while the highest probiotic dosage resulted in levels higher than that of both the negative control and sham injected groups. These data suggest that probiotics may promote antimicrobial activity in the host by increasing intestinal iNOS gene expression and thus provide a means of protection against pathogens soon after hatch when the chick is immunologically most vulnerable.
Other than iNOS on DOH, our results suggest the primary effect of probiotics is to downregulate immunerelated gene expression within the intestine. The expression of these genes in the probiotic-treated groups could be repressed as an outcome of probiotic supplementation or, alternatively, may be the result of inhibitory effects of probiotic bacteria on pathogen colonization. A reduction in intestinal colonization by pathogenic bacteria may have eliminated the need for the induction of these genes. Probiotics have demonstrated their ability to modulate the levels of several cytokines; however, discrepancies have been noted due to differences in the probiotic strains, combinations of probiotic strains, and presence or absence of a challenge Brisbin et al., 2010; Lee et al., 2010) . Correlating with our findings, several studies have noted reduction in immune-related factors. Akbari et al. (2008) found the expression of antimicrobial peptides in the cecal tonsils to be downregulated due to probiotic supplementation during a Salmonella infection. The authors speculate that the observed decrease in gene expression could be a result of providing probiotics during a Salmonella infection or, possibly, a reduced Salmonella load in the intestine (Akbari et al., 2008) . In a study to compare the efficacy of the antibiotic avilamycin and probiotics on the humoral immune response, Mountzouris et al. (2009) found that both treatments resulted in reduced levels of plasma IgA and IgG and intestinal IgA against Salmonella Enteritidis when compared to the challenged control and that those levels were not different from those of the negative controls. Haghighi et al. (2008) evaluated gene expression in the cecal tonsils of chicks treated with probiotics and challenged with Salmonella and found that IL-12 and IFN-γ levels were repressed by probiotic treatment and these results were correlated with reduced intestinal Salmonella colonization. While evaluating the effects of feeding a Lactobacillus-based probiotic during an Eimeria acervulina infection, Dalloul et al. (2003) observed that probiotic supplemented groups displayed reduced oocyst production and lower antibody levels against a recombinant coccidial antigen in intestinal secretions than the non-supplemented group. The immunosuppressive effects seen in these studies could be a result of lowered invasive potential of the pathogens, enhanced clearance, and accelerated recovery caused by the probiotic treatments. Furthermore, the bacterial strains used as probiotics are normal inhabitants of the chicken intestine and it has been speculated that commensal bacteria have the ability to produce proteins with immunosuppressive effects (Brisbin et al., 2010) . It is of note that no challenge was utilized during the current study, but these results provided rationale for further analysis to elucidate the impact of this application on development of the immune system during infection. In that experiment, in ovo probiotic supplementation of broiler chicks subjected to an Eimeria challenge resulted in reduced gross lesion severity in all intestinal segments evaluated, thus providing better evidence of potentially higher degree of protection against enteric challenges (Pender et al., 2016) .
In conclusion, our data demonstrate that in ovo supplementation of Primalac does not impact hatchability and can enhance performance of broilers during the first week post-hatch. Furthermore, in ovo inoculation of Primalac acts as an immunomodulator by altering the expression of several immune-related genes within the ileum and cecal tonsils. The underlying mechanisms of probiotic activity are multi-faceted with effects on both the innate and adaptive immune systems. To our knowledge, this is the first study to evaluate the effects of in ovo administration of the probiotic product Primalac W/S on performance and immune profile in broiler chicks. This study reveals the immunoregulatory effect of probiotics on intestinal immunity in poultry and provides justification for further study to investigate the various effects of Lactobacillus-based probiotics in poultry and in ovo supplementation as a means of promoting early establishment of beneficial bacteria and immune system development.
